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ABSTRACT
Endocannabinoid-Mediated Synaptic Plasticity in
the Ventral Tegmental Area and Hippocampus
Lindsey Nicole Friend
Department of Physiology and Developmental Biology, BYU
Doctor of Philosophy
Neuroscience
Synaptic plasticity is the process whereby connections between neurons can be altered in
an experience dependent manner. For example, drugs of abuse alter plasticity in the ventral
tegmental area (VTA) of the midbrain. A large amount of research has been applied to
uncovering the mechanism whereby synapses on the reward signaling dopamine cells is altered,
however, less is known regarding the VTA inhibitory GABA neurons. Our objective was to
examine the ability of GABA neurons to exhibit plasticity, and determine how drugs of abuse
could influence it. Here we report a novel type of plasticity of excitatory neurotransmission onto
VTA GABA cells. This plasticity is dependent on the metabotropic glutamate receptor 5, to
signal for diacylglycerolipase alpha to make the endocannabinoid 2-arachadonoyl glycerol to
signal via cannabinoid receptor 1 (CB1). Marijuana and cocaine are drugs of abuse that have
been shown to alter the endocannabinoid system. Tetrahydrocannabinol is the active ingredient
in marijuana, and is a known agonist of CB1, and cocaine is able to attenuate endocannabinoid
signals. We tested the effects of these drugs on VTA GABA plasticity and found that it can be
blocked by chronic injections of tetrahydrocannabinol, as well as acute and chronic injections of
cocaine. If VTA GABA neurons are depressing excitatory inputs, that could lead to less
inhibition onto VTA dopamine cells, and therefore, more reward signaling in the brain. This new
type of plasticity could be an additional mechanism whereby cocaine and marijuana exert their
rewarding and addictive effects.
Another brain structure known to exhibit use-dependent plasticity is the hippocampus,
which is involved in learning and memory. The stratum oriens is a layer of inhibitory
interneurons in the hippocampus that is involved in feedback inhibition onto the principle
excitatory cells in the stratum pyramidale. Our goal was to determine whether oriens
interneurons were capable of producing an endocannabinoid signal, and if so, whether they could
influence plasticity. We identified 2 major subtypes of oriens interneurons, oriens lacunosummoleculare cells, and parvalbumin-positive basket cells, which are capable of receiving and
producing an endocannabinoid signal. Furthermore, we demonstrated that one such
endocannabinoid, anandamide, is responsible for signaling for synaptic plasticity. This plasticity
is also dependent on CB1, and is unique in that there are few examples of CB1 signaling for
potentiation rather than depression. Collectively, these experiments demonstrate two
mechanisms of endocannabinoid mediated synaptic plasticity, which could influence reward
signaling, addiction and memory.
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Dissertation

CHAPTER 1: Introduction
Mammalian brains are among the most complex and elaborate structures in nature, which

allow animals to rapidly sense, interpret and act in their changing environment. The ability to
recruit previous knowledge to future decision making is essential to everything from survival
skills such as finding food, to building and maintaining relationships. While most of the gross
anatomy is present and intact from birth, a mechanism must exist for which new connections can
be made or altered. Novel memories and skills are not encoded in new neurons, but changeable,
or plastic synapses that can quickly be modified. Several disease states result from the inability
to alter synapses that encode new memories, or retrieve stored ones, including dementia and
Alzheimer’s disease that according to the Alzheimer’s Association currently effects over 5
million Americans. In addition to explicit memories, the same mechanisms can allow a person to
remember rewarding events such as eating. While this process can be useful for healthy
activities, it can be hijacked by abusable substances to produce implicit memories of rewarding
drugs leading to addictive behaviors. Certainly, understanding the mechanism of various types of
synaptic plasticity can provide applicable insights to several disease states.
Synaptic Plasticity is a process whereby synapses can be strengthened or weakened based
on the activity of the cells around them by either presynaptically altering neurotransmitter
release, or postsynaptically modifying the receptor trafficking to and from the membrane.
Plasticity is a critical event that allows us to modify brain activity based on the experiences in
our lives and is thus experience-dependent brain modification. Two major forms of synaptic
plasticity are present in the brain, Long-term potentiation (LTP) and long-term depression
(LTD). For post-synaptic LTP to occur, there must be a large calcium ion influx through NMethyl-D-Aspartate (NMDA) glutamate receptors, which triggers α-Amino-3-hydroxy-51

methyl-4-isoxazolepropionic acid (AMPA) receptors to be inserted into the membrane. These
non-selective cation channels allow the post synaptic cells to respond to further glutamatergic
transmission. In contrast, a weaker signal would result in a lower amount of calcium ion influx
which results in AMPA receptor internalization, known as LTD [1]. Plasticity has been observed
in various brain regions, notably, the hippocampus where it is crucial for memory encoding and
consolidation.
The Hippocampus is a highly organized and intricate region of the temporal lobe, and
contains a variety of cell types, and is known to be involved in memory consolidation. The
hippocampus consists of several layers including stratum radiatum, stratum pyramidale, and
stratum oriens, which can be divided in main sub-regions including cornu ammonis 1 (CA1),
CA2 and CA3. Distributed in these layers are both excitatory and inhibitory neurons. Excitatory
pyramidal cells are located in stratum pyramidale of the CA regions and diverse inhibitory
interneurons are present in stratum radium and stratum oriens [2]. Other less well known forms
of plasticity in addition to NMDA dependent forms also occur in the brain mediated by various
other mechanisms such as induced by lipid messengers known as endocannabinoids.
Endocannabinoids (eCBs) are produced by components of the lipid membrane, a reaction
catabolized by various enzymes, for example phospholipase c, and diacylglycerol lipase α,
normally following second messenger activation. Usually, upon post-synaptic activation of type
1 metabotropic glutamate receptors, enzymes are recruited to produce eCBs which then can
retrogradely travel to the pre-synaptic cell to alter neurotransmission via cannabinoid receptor 1
(CB1) [3]. The two best characterized endocannabinoids are anandamide and 2-arachadonyl
glycerol (2-AG). Anandamide, a common eCB, is produced by n-acylphosphatidylethanolamine
phospholipase D (NAPE-PLD) and can bind to cannabinoid receptor 1, or other G-protein
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coupled receptors throughout the brain. It is then degraded by the enzyme fatty acid amide
hydrolase (FAAH). When this enzyme is inhibited, baseline anandamide is increased. [4, 5]. 2AG is produced in the brain by diacylglycerol lipase alpha (DAGLα) and is also involved in
retrograde signaling via CB1 [6] and other receptors. It remains unknown whether some or all of
the various subtypes of interneurons utilize eCBs for plasticity.
Hippocampal interneurons are a diverse group, and can be classified into several different
subtypes based on their function, projections, and firing pattern. Often interneuron subtypes are
characterized into these groups using calcium binding proteins and neuropeptides, including
somatostatin, cholecystokinin and parvalbumin (Freund, 1996). The stratum oriens of the CA1
region of the hippocampus houses interneurons of these varying types. Oriens lacunosummoleculare (O-LM) interneurons are one such group, and can be identified by the expression of
cholecystokinin and somatostatin, as well as a regular and fast spiking pattern and sag potential
upon injection of hyperpolarizing current [7, 8]. O-LM cells are named for their morphology,
with somas residing in stratum oriens and distant projections to stratum lacunosum moleculare.
Another subtype is parvalbumin positive basket cells, which project locally and lack a sag
potential. These cells are also involved in network oscillations in the hippocampus [9]. While
projections and spiking patterns are well defined in these neurons, information on
endocannabinoid biosynthetic capability, or eCB-dependent plasticity of these interneurons is
lacking. Based on the role interneurons play in feed-forward inhibition and widespread network
control and oscillations, a thorough study of the mechanism of their plasticity is timely and
relevant.
Other areas of the brain experience endocannabinoid-mediated plasticity as well, such as
the ventral tegmental area (VTA). The VTA is critically involved in reward stimuli, including

3

behavior components of rewarding and aversive stimuli. The VTA projects to structures such as
the nucleus accumbens and prefrontal cortex, where reward is mediated and conscious
perception of the reward occur, respectively. The VTA contains both dopaminergic neurons
projecting to the nucleus accumbens, and GABAeric neurons that regulate DA neuron firing and
DA release. GABA cells are common and heterogeneous throughout the VTA, and can be
innervated by multiple sources, including excitatory glutamatergic input from distant prefrontal
cortical cells [10]. As the VTA is so important to reward, alterations to its synaptic activity have
been implicated in forming addictions.
Drugs of abuse, such as cocaine and marijuana, are known to modulate neuronal activity
in the VTA and result in addiction [11, 12]. While increased dopamine release in nucleus
accumbens mediates the initial reward, synaptic plasticity of VTA circuits is thought to mediate
the addiction [13, 14]. Cocaine produces a reward by blocking the dopamine transporter DAT,
resulting in dopamine remaining in the synapse for a longer period of time. Δ9tetrahydrocannabinol (THC), the active component in marijuana activates CB1 receptors. This
can lead to reward by disinhibiting or removal of inhibition to dopamine cells. While both
cocaine and THC increase dopamine to mediate reward, they can also produce lasting
associations, modified synapses in the VTA that can lead to an addictive state.
For example, eCBs and CB1 mediate plasticity either directly by THC or via cocaine
which decreases postsynaptic mGluR activation and therefore, eCB synthesis (Luscher &
Malenka, 2011). The link between CB1 and drugs of abuse is demonstrated in a variety of
conditions, suggesting an additional role of endocannabinoids in the reward effects via increased
dopamine, and addiction processes through synaptic plasticity. Figure 1 summarizes the known
targets of drugs of abuse on dopaminergic neurons. The right side highlights the synapse of
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interest, between the glutamatergic cell and the VTA GABA cell where we identify a novel form
of CB1-dependent synaptic plasticity.
Specific Aims
The effects of drugs of abuse on ventral tegmental area physiology is a relatively new
focus of research for many years with the hope of unraveling the molecular processes of reward
and addiction states. While much is known regarding alterations of synaptic plasticity in
dopamine cells, the possible influence of GABA plasticity on reward remains unknown. Our aim
was to determine the mechanism of synaptic plasticity in VTA GABA cells, and examine the
influence of cocaine and THC on this plasticity.
In addition, we studied the endocannabinoid capabilities of hippocampal stratum oriens
interneurons. These inhibitory cells are regulators of the hippocampal principle cells. We wanted
to determine whether these neurons are capable of producing endocannabinoid signals, and how
they influence synaptic plasticity.
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Figure 1.1: VTA Reward Circuitry. Rewarding behaviors can be associated with increases in
firing rate of VTA dopamine neurons projecting to the nucleus accumbens. It is known that some
drugs of abuse directly target dopamine cells by modulating plasticity at both the inhibitory
(solid) and excitatory (open) synapses. However, the modulation of excitatory inputs onto
GABA cells remains unknown, but likely could also affect dopaminergic neurons indirectly.
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CHAPTER 2: CB1-dependent LTD in Ventral Tegmental Area GABA Neurons:
A Novel Target for Marijuana

Lindsey Friend, Jared Weed, Phil Sandoval, Jeffrey Edwards
Abstract
Ventral tegmental area neuronal circuits have been implicated in reward processing. The
activity of the dopamine cells that signal reward are regulated by neighboring GABA cells that
inhibit them. While the physiology and plasticity of dopamine cells has been thoroughly studied,
less is known about the plasticity of GABA cells. Here we describe a novel form of excitatory
plasticity in VTA GABA neurons, and demonstrate how this plasticity can be modified by ∆9tetrahydrocannabinol, the active ingredient in marijuana. Using whole cell voltage-clamp
electrophysiology in GAD67-GFP mouse VTA slices, excitatory inputs on fluorescent GABA
cells were recorded. A CB1-dependent long-term depression can be induced by high-frequency
stimulus, which is dependent on type 1 metabotropic glutamate receptors, and cannabinoid
1(CB1) receptors. CB1 agonists r(+)methanandamide, 2-AG, WIN55, and Δ9tetrahydrocannabinol mimic and occlude LTD. This LTD was absent in CB1 knock-out mice,
but preserved in CB1 heterozygous littermates. Chronic injections of Δ9-tetrahydrocannabinol
significantly occluded LTD compared to vehicle injections, however, a single 24-hour exposure
was insufficient to occlude it. This novel form of plasticity wherein VTA GABA cells can
depress excitatory inputs, could lead to disinhibition of nearby dopaminergic cells.
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Introduction
Drug addiction represents a significant health and economic issue around the world. The
United States spends over $193 billion dollars annually on costs related to illicit drug abuse.
While there is variation in the mechanism of each drug of abuse, the common theme among
drugs of abuse is that they alter ventral tegmental area (VTA) circuitry and function, usually to
enhance dopamine release [15]. However, subsequent to the acute actions of drugs of abuse,
changes often occur that continue after the drug has left the body. These synaptic changes in
VTA, or its projections, mediate some of the addictive components of drugs of abuse. All
addictive psychoactive substances examined to date induce long-term changes of excitatory
synapses of VTA DA neurons, while non-addictive psychoactive substances do not [16]. For
example, one exposure to cocaine can cause LTP of excitatory input to VTA dopamine cells
[17]. While the brain regions relevant to addiction plasticity are primarily the VTA and nucleus
accumbens, the mechanisms of plasticity are certainly more numerous. Rewarding drugs increase
midbrain dopamine levels through a variety of strategies. Within the VTA, dopaminergic cells
are involved in motivation and learned reward. Drugs of abuse enhance DA levels more than
normal rewarding behaviors, and cause synaptic modifications leading to addiction. Addiction is
the compulsive drive to self-administer drugs even after mitigation of DA enhancements.
Endocannabinoids (eCBs) mediate many forms of plasticity, in particular long-term depression
(LTD). eCBs can signal for LTD and cause a decrease in synaptic strength is weakened due to
decreased neurotransmitter release or endocytosis of post-synaptic receptors. eCBs are more
recently characterized lipid-based chemicals that induce plasticity at locations throughout the
brain [5], including the VTA [18]. The eCBs include 2-arachidonylglycerol (2-AG) and
anandamide that activate receptors such as cannabinoid receptor 1 (CB1) and transient receptor
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potential vanilloid 1 (TRPV1) [6, 19]. These receptors have been correlated to reward and
addiction in the VTA [20, 21]. The regulation of eCB production share common mechanisms
throughout the nervous system [22]. Synthesis of eCBs 2-AG and anandamide often occur in the
postsynaptic cell, usually due to activation of type I metabotropic glutamate receptors (mGluRs)
[23]. When produced, these hydrophobic molecules escape from the postsynaptic cell and either
act as retrograde messenger for presynaptic receptors or receptors on adjacent cells. One such
presynaptic receptor is CB1, which is particularly relevant to addiction due to its ability to bind
to the psychoactive ingredient in marijuana, ∆9- tetrahydrocannabinol (THC). THC is known to
be rewarding and potentially addictive, especially in adolescents. Indeed, an addiction state
known as Cannabis Use Disorder is on the rise. The recent legalization of marijuana in some
states will only increase the public issues associated with it and thus the demand for studies
regarding its effects on reward, addiction and cognition. THC is known to increase midbrain
dopamine levels, which is consistent with the current theory of addiction [24].
While illicit drugs cause various synaptic modifications onto DA cells, data regarding
drug modification of excitatory synapses onto GABA neurons is conspicuously absent.
Therefore, examining VTA GABA neurons is timely as drugs of abuse targeting these neurons,
altering their activity and synaptic plasticity, could cause addictive behaviors, as decreasing
GABA cell activity reduces inhibition to DA cells, thus enhancing DA release. Our goal was to
study the mechanism of plasticity of excitatory inputs onto VTA GABA neurons and determine
whether THC can influence this plasticity.
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Methods
All experiments were performed in accordance with Institutional Animal Care and Use
Committee protocols and followed NIH guidelines for the care and use of laboratory animals.
IACUC protocols for all experimental protocols were approved by the Brigham Young
University Institutional Animal Care and Use Committee, Animal Welfare Assurance Number
A3783-01.
Male CD1 GAD67-GFP knock-in mice (P15-P30) were used so that GABA cells in the
VTA could be positively identified using fluorescence [25]. Male CB1 knock-out mice (Dr. Ken
Mackie’s Lab) were bred to female GAD67-GFP+ mice to obtain knock-out and heterozygous
littermates.
Mice were anesthetized with isoflurane and decapitated with a rodent guillotine. Brains
were rapidly removed and sectioned horizontally on a vibratome at 300µm using an ice cold,
sucrose-based cutting solution composed of 220 mM sucrose, 0.2mM CaCl2, 3 mM KCl, 1.25
mM NaH2PO4, 25 mM NaHCO3, 12 mM MgSO4, and 10 mM glucose. After sectioning the
slices were placed in an incubator at 37 degrees Celsius, where they remained until recording.
Recordings began at least one hour after cutting while tissue was stored in oxygenated artificial
cerebral spinal fluid composed of 119 mM NaCl, 26 mM NaHCO3, 2.5mM KCl, 1 mM
NaH2PO4, 2.5mM CaCl2, 1.3mM MgSO4, and 11mM glucose with 100µM picrotoxin.
The ventral tegmental area was visualized using an Olympus Center Valley, BX51W1
microscope with a 40x water immersion objective. Patch pipette resistance was 3.5–5.5 MΩ.
Cells were held at −65 mV throughout the recording. Cells were patched with a glass pipette
filled with internal solution composed of 117mM cesium gluconate, 2.8 mM NaCl, 20 mM
HEPES, 5 mM MgCl2, and QX0314 (Tocris) (pH 7.28, 275–285 mOsm). Slices were
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oxygenated with 95% O2, and 5% CO2 in artificial cerebrospinal fluid was pumped into and out
of the recording chamber throughout the experiment. Current traces were recorded using
Multiclamp 700B amplifier (Molecular Devices, Sunnyvale, CA, USA). Signals were filtered at
4 kHz and digitized with an Axon 1440A digitizer (Molecular Devices) connected to a Dell
Personal Computer with pClamp 10.2/10.5 Clampex software (Molecular Devices). Plasticity
was induced using 2 stimulations at 100Hz, 20 seconds apart. Cells used for depolarization
induced suppression of excitation (DSE) experiments were initially held at -65mV, then raised to
0mV for 10 seconds before being returned to -65 mV. The peak amplitude of the induced
excitatory post-synaptic current (EPSC) was calculated using Clampfit 10.5 software (Molecular
Devices) and graphed using Origin 7.5 Within individual experiments, current traces were
averaged by minute (6 sweeps/minute). Wilcoxon matched pairs analysis was used to obtain pvalues for the paired-pulse ratios and coefficient of variance. All other p-values were obtained by
a two-way unequal variance t-test comparing the 5 minutes before conditioning to 15-20 minutes
post conditioning.
Picrotoxin (0.2mM), and Capsazepine (10µL) were purchased from Abcam. APV
(50µL), AM-251 (2µM), 2-AG (50µM), R(+)methanandamide (50µL), GDPβS (500µM), DHPG
(100µL), Win55,212-2 (10µM), and RHC80267 (10µM) were purchased from Tocris. CNQX
(10µM) was purchased from Alomone Labs. Δ9-tetrahydrocannabinol was purchased from
Sigma-Aldrich, and the NIDA Drug Supply Program. THC was administered via intraperitoneal
injection at 10mg/kg.
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Results
Critical to the success of this study was to positively identify VTA GABA neurons. This
was done by using a GAD67-GFP mouse model where GAD67-expressing GABA cells
fluoresce green. This was necessary as electrophysiological methods such as Ih and sag potential
that many prior studies used to discriminate the relatively fewer GABA cells are now considered
fallible in their ability to discriminate GABA cells from DA cells [10, 26, 27]. Therefore, this
study is one of the few unequivocal studies of VTA GABA cell plasticity. To examine the
ability of VTA GABA cells to exhibit synaptic plasticity of their excitatory inputs we applied
either 5 Hz or 100Hz high frequency stimulus (HFS) to voltage clamped GAD67-GFP positive
GABA neurons in the mouse VTA. While 5 Hz stimulation produced long-term depression
(LTD) in 30% of cells (data not shown), we observed a more consistent LTD following HFS in
71% of GABA cells (40±3.2% decrease in EPSC amplitude; Figure 2.1A). Therefore, we used
HFS stimulus throughout these studies. Control rundown experiments did not exhibit depression,
and proved significantly different than HFS-LTD (Figure 2.1B). Next, in order to determine
whether this plasticity was pre- or postsynaptic, 1/CV2, paired pulse ratios (PPRs) and failure
rates were analyzed (Figure 2.1D-F). These data suggested a presynaptic mechanism for the
observed plasticity.
Endocannabinoids are signaling molecules involved in multiple types of presynaptic
plasticity. Therefore, we examined the application of a non-hydrolyzable form of anandamide,
R(+)methanandamide, to see if it would also induce depression of EPSCs. Indeed similar to HFS,
R(+)methanandamide induced significant depression (Figure 2.2A). The usual mediator of
anandamide production is type 1 mGluR activation. To confirm this we applied the mGLuR
agonist DHPG and once again observed significant depression (Figure 2.2B). In the presence of
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the mGluR5 antagonist MPEP, HFS-LTD was blocked, suggesting that mGluR5 are required and
sufficient for this plasticity (Figure 2.2C). To further confirm that a postsynaptic G-protein
coupled receptor such as mGluR was involved, a GDP analogue, GDPβS, was added to the
internal solution to block post-synaptic g-proteins (Figure 2.2D). After waiting 10 minutes for
GDPβS to dialyze into the cell HFS was applied. In the presence of GDPβS LTD was inhibited,
suggesting that postsynaptic G-protein coupled receptors are necessary to initiate LTD at this
synapse.
Among the candidate receptors known to bind eCBs such as anandamide that could
induce plasticity are TRPV1 and CB1. The TRPV1 antagonist capsazepine did not block HFSinduced LTD, suggesting that TRPV1 is not involved (Figure 2.3A). However, application of the
CB1 antagonist AM-251 effectively blocked LTD (Figure 2.3B), suggesting CB1 is required for
HFS-induced LTD.
To verify the presence of CB1 receptors at the synapse, we applied CB1 agonists. Win
55,212-5, an exogenous CB1 agonist, and 2-AG an endogenous agonist, both induced depression
of ESPCs (Figures 2.4A and 2.4C). The specificity of Win 55,212-2 for CB1 is noted as AM-251
blocked Win 55,212-2-induced depression (Figure 2.4B). To further confirm the involvement of
eCBs and CB1 in HFS-LTD, occlusion experiments were done in which the cells were treated
with the CB1 agonist Win55,212-2, then HFS was applied. Further depression by HFS was
occluded, suggesting a single, common pathway of CB1 activation and HFS-induced LTD
(Figure 2.4A).
To show the necessity of the endogenous eCB 2-AG, and to determine whether its
production is post-synaptic, RHC 80267 was applied to the intracellular solution to block the
enzyme diacylglycerol lipase α (DAGLα), which produces 2-AG. After whole-cell acquisition,
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RHC 80267 was allowed to dialyze into the cell for at least 10 minutes. When post-synaptic
DAGLα was blocked, no significant depression was seen following HFS (Figure 2.4D).
Blocking HFS-LTD by post-synaptically inhibiting 2-AG synthesis suggests that the 2-AG
involved in HFS-LTD is made directly by the GABA cell.
To further confirm that eCBs are being produced post-synaptically in GABA cells, we
examined an additional type of plasticity unique to CB1: depolarization-induced suppression of
excitation (DSE). We observed a significant depression following a 10 second depolarization to
0mV, which was surprisingly persistent throughout the duration of the recording (Figure 2.4D).
AM-251 blocked this depression (Figure 2.4E), suggesting VTA GABA cells can produce the
eCBs that can bind to CB1 in this type of plasticity.
To verify CB1 involvement using a genetic method, we utilized CB1 knock-out mice and
heterozygous littermates. HFS continued to produce a significant depression in CB1+/- mice
(Figure 2.5A); however, LTD was not observed in CB1-/- (Figure 2.5B). Collectively our data
suggests CB1 is required for HFS-LTD.
As CB1 can be activated by THC, this novel form of plasticity we characterized may
have relevance to THC-induced reward or addiction-like phenomena such as Cannabis-use
disorder. Therefore, we next investigated whether the observed eCB-dependent HFS-LTD could
be modified by drug exposure. Extracellular bath application of THC produced a significant
depression of VTA GABA EPSCs (Figure 2.6A), and this effect was blocked in the presence of
AM-251 (Figure 2.6B), demonstrating THC specificity for CB1. In CB1+/- mice, extracellular
THC also produced depression (Figure 2.6C), but not in CB1-/- mice (Figure 2.6D), again
confirming specificity. We initially wanted to determine if acute THC bath application could
occlude or alter HFS-LTD. Indeed, bath application with THC for 10 minutes occluded HFS-
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LTD (Figure 2.6 F). Therefore, THC acutely depresses GABA cell excitability, as well as block
LTD induction.
As drugs of abuse cause long-term synaptic modifications may facilitate addiction, we
examined the role of acute and chronic THC injections on this LTD. To do this, mice received
THC IP injections to study synaptic modification by a single injection, or chronic THC exposure.
As THC is less addictive we anticipated that a single injection might not have a long-term effect
on plasticity, though chronic injections might, as long-term marijuana users are prone to THCinduced issues. Indeed, single injection failed to occlude LTD (Figure 2.7A). However, chronic
injections (7-10 consecutive days) occluded LTD in slices (Figure 2.7B), and in a few cells
tended to enhance EPSCs. This suggests that persistent, long-term THC exposure can modify
plasticity at the glutamatergic inputs onto VTA GABA cells of juvenile to adolescent age mice
that may contribute to some of the long-term consequences of THC use.
Discussion
The present study demonstrates a novel CB1-dependent LTD of excitatory inputs to VTA
GABA cells that can be modified by THC, as summarized in Figure 2.8. HFS-LTD is induced by
CB1 activation that is mediated by post-synaptically produced 2-AG, formed by PLC and
DAGLα via mGluR5 activation and postsynaptic calcium release. THC mimics this plasticity via
the CB1 pathway when applied acutely and occludes it when injected chronically. Therefore, this
novel form of plasticity has the potential to influence reward and addiction states following THC
exposure.
To date no one has carefully studied excitatory plasticity of VTA GABA cells at the
cellular level, despite the fact that GABA cells mediate reward consumption [28], associative
learning of reward [11], conditioned place preference [29], and conditioned place aversion [30].
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As GABA cells are critical to reward, it illustrates the importance of this study, the first to
identify synaptic plasticity of excitatory inputs to VTA GABA cells that can modify GABA cell
activity by depressing it. While one other study examined plasticity of excitatory inputs to
GABA cells, this study employed a pairing protocol (+10 mV, 200 stimuli at 1 Hz) that failed to
induce either LTP or LTD [31]. However, this pairing protocol is normally employed to examine
NMDA-dependent plasticity. The plasticity we observed is likely mGluR dependent, which
accounts for the observed difference. We report that using HFS (2 trains of 100 Hz for 1s, each
train 20s apart) protocol does indeed cause depression of EPSCs in VTA GABA neurons, in a
CB1-dependent manner. As an important note, there are likely more eCB receptors at this
synapse than just CB1 as R-(+)methanandamide and DHPG produce a larger effect than CB1
agonists alone, however CB1 appears to be the only eCB receptor required for this LTD. Finally,
while VTA DA cells exhibit DSE of excitatory inputs via presynaptic CB1 receptors [32]. It is
important to note that our DSE data indicate that GABAs can modulate their own activity by
producing eCBs themselves rather than relying on DA cells for their production.
CB1-dependent forms of LTD exist in many brain regions [33], with the list growing as
the eCB system is widely expressed. This plasticity is a form of use-dependent plasticity and the
eCB system is now recognized for its importance in synaptic plasticity throughout the brain. The
best cellular correlate to compare VTA GABA cells is likely the striatum [34]. Other examples
of plasticity can be found that are strikingly similar to the plasticity described here. For example,
LTD can be initiated between glutamatergic inputs onto striatal GABA neurons, which is
dependent on presynaptic CB1 and post-synaptic activation of mGluRs and eCB synthesis [35,
36].
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The importance of GABA cell involvement in reward either directly through axonal
projections to brain regions outside the VTA or indirectly by regulating DA cell activity,
highlight the critical nature in understanding GABA cell modification by synaptic plasticity, a
necessary element in understanding VTA reward mechanisms. Directly, GABA cells in the VTA
project to the nucleus accumbens (NAc) where they enhance associative reward learning [11]
and to the tegmental pedunculopontine nucleus where they mediate the dopamine-independent
reinforcing properties of opioids [37]. Indirectly, decreased GABA cell activity results in
increased DA cell activity by disinhibiting DA neurons [29], and alternatively increased GABA
cell activity inhibits DA cells activity and DA release [28, 30], which alter reward behavior.
Thus, this study fills a critical missing piece of our understanding of reward physiology and
suggests this novel form of glutamatergic LTD could modulate reward behavior either directly
by its projections or indirectly by modulating DA levels via DA cell disinhibition. Indeed, VTA
DA cells are under tonic inhibition from GABAergic cells, including from the recently identified
RMTg [38], making any change in GABA function pertinent to DA cell function as only phasic
or brief and inhibition or excitation of DA cells mimic negative reward [39] or reward behavioral
conditioning [40], respectively.
Regarding reward, acute exposure to THC can directly modify dopaminergic cells by
increasing their firing rate. This is thought to occur via presynaptic CB1 receptors on GABA
inputs to dopamine cells, thus resulting in disinhibition of DA cells (Szabo- your ref #12 and
maybe others). Our current study proposes a novel mechanism that THC could induce reward,
namely that THC reduces excitatory input to GABA cells and thus decreasing inhibition to VTA
DA cells via disinhibition, which is a similar mechanism but one synapse upstream in the circuit.

17

Therefore, acutely ingested or bath applied THC could simultaneously alter both synapses that
synergistically result in increased DA and reward.
To date all addictive psychoactive substances examined induce long-term changes of
excitatory synapses of VTA DA neurons, while non-addictive psychoactive substances do not
[16]. This finding portends the importance of understanding forms of glutamatergic VTA GABA
plasticity and their potential role in addiction. Drug-evoked or drug-inhibited synaptic plasticity
alters VTA circuits and thus can lead to drug addiction by creating drug-adaptive behaviors.
While the true addictive nature of THC is debated, alterations in the mesolimbic pathway
following chronic THC use is particularly relevant for adolescents. Indeed, human adolescent use
of marijuana correlates to decreased IQ and cognitive impairment [41], cortex development
issues, schizophrenia [42], alterations in nucleus accumbens [43], depression and anxiety and
increased probability for long-term substance abuse [44, 45]. Therefore, studies examining THC
impacts on adolescent brain are extremely important, particularly in the reward center. The mice
age range employed here correlate to juvenile/adolescent ages, making this study of potential
importance as to THC effects on immature brain, which could have implication in adolescent
related increases in substance abuse.
While a single THC injection was sufficient to alter plasticity in the NAc [46], we
anticipated and noted that a single injection of THC had no effect on CB1-dependent LTD.
However, chronic THC did occlude this LTD, suggesting this occlusion mechanism responds to
only chronic repeated usage. As during cannabis withdrawal there is a decrease in mesolimbic
dopamine [47], it is possible that THC-occluded LTD prevents GABA cells from reducing their
activity, potentially contributing to some of decreased DA levels in withdrawal.
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The effects of chronic THC use were recently reviewed by Colizzi et al [48]. The
plasticity described here is a similar mechanism to previously reported acute and chronic
synaptic modifications, wherein a pre-synaptic CB1 receptor alters glutamate plasticity affecting
changes in mesolimbic dopamine, however ours is the first study to identify this plasticity on
GABA neurons.
Again, while the addiction potential of THC is not completely apparent, this CB1dependent glutamatergic synaptic plasticity may also be modified by more addictive drugs
making it critical to examine. Cocaine is known to modify glutamate plasticity onto DA cells in
nearly every study [14, 29, 49]. In addition, cocaine blocked eCB forms of plasticity such as a
CB1-dependent form of LTD in the NAc [49]. Another example where the pharmacological
inhibition of the synaptic breakdown of the eCB anandamide enhanced the increase of VTA DA
release caused by cocaine administration in mice, which demonstrates that CB1 activation
enhances the effects of cocaine in the VTA [50]. Finally, cocaine can stimulate 2-AG to suppress
GABA activity onto dopaminergic neurons via CB1 [51].Therefore, cocaine can modify eCBdependent forms of plasticity and thus this plasticity may have relevance to modification of other
drugs of abuse. Indeed, this is a matter of current investigation.
Significance
Marijuana use and legalization has recently been an issue for multiple states. Although
marijuana is the most commonly used illicit drug, the implications of legalized, widespread or
continued usage are speculative. Additionally, there are misconceptions regarding whether
marijuana can be addictive. THC may be more addictive that previously thought, especially for
adolescents, and the addiction state Cannabis Use Disorder is on the rise. After smoking and
alcohol, marijuana ranks second behind opiate abuse for those entering substance abuse
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treatment programs, portending the importance of understanding THC’s effect on the brains
reward center. If nothing else, state legalization of marijuana will only increase its usage and
public issues associated with it as well as the demand for studies regarding its effects on reward,
addiction and cognition. Even THC for medical purposes will be important to understand, again
particularly when it is prescribed for adolescents. This study in adolescent mice emphasizes vital
role VTA GABA cells play in reward circuitry, and the potential synaptic remodeling that can
occur after THC use.
Conclusion
The results of the present study shed more light on how the population of VTA GABA
neurons, an important cell in the brain’s reward circuit, can be affected in the long term by
upstream excitatory activity. This study specifically addresses a mechanism whereby marijuana
could exert its rewarding or addictive effects. Although marijuana addiction has a high
prevalence among illicit drugs [52], it remains difficult to treat partly because its addictive
mechanisms are poorly understood [53]. This study shows how both glutamatergic activity and
cannabinoid receptor activation are tied to LTD of VTA GABA neurons. These events can lead
to disinhibition of VTA DA neurons. The resulting increase of DA in the VTA and its
projections in turn could mediate rewarding and addictive behavior. As those attempting to
overcome their addiction often relapse, novel targets to treat addiction are essential.
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Normalized EPSCs

A2.0

Figure 2.1: Pre-Synaptic Long-Term Depression
(LTD) In VTA GABA Cells. A. Glutamate
currents recorded from GAD67-GFP positive
VTA GABAs. 100Hz high frequency stimulus
(HFS) induces long-term depression. Responses
were reduced by 40±3.2% compared to baseline
(n=14, p<0.001 comparing baseline to post
conditioning). B. No treatment controls showed
no change in EPSC amplitude, which
demonstrates HFS-LTD is not due to washout
effect (n=8). Following HFS the coefficient of
variance (1/CV2) decreased, paired-pulse ratio
increased, and failure rates increased (n=15 for
1/CV2 and PPR, n=6 for failure rates, p>0.05
for each) suggesting a presynaptic mechanism
for HFS-LTD. Scale bars 100 pA, 10 msec.
Plots, mean with s.e.m. Arrow indicates 100Hz
high frequency stimulus (HFS).
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Figure 2.2: Endocannabinoids (eCBs) Are Likely Involved In VTA GABA Cell Plasticity.
eCBs are signaling molecules involved in presynaptic plasticity mechanisms. A. A nonhydrolyzable form of an eCB, R(+)methanandamide, induces depression of glutamatergic
neurotransmission (n=6, p<0.001). B-C. Group 1 mGLuRs are normally required to signal for
eCB synthesis. The Group 1 mGluR agonist DHPG caused depression similar to HFS-LTD (n=7,
p<0.001) and the antagonist MPEP blocked HFS-LTD. Therefore, mGluR5 are required and
sufficient for depression. D. To further test for the necessity of a post-synaptic g-protein coupled
receptor (such as an mGluR), a GDP analogue GDPbS was added to the internal solution, and
indeed blocked HFS-LTD (n=7).

23

A.

B.

2.0
AM251 (2µM)

Capsazepine (10µM)

1.5

Normalized EPSCs

Normalized EPSCs

2.0

1.0
0.5
0.0

0

10

20

30

40

50

60

1.5
1.0
0.5
0.0

Time (Min)

0

10

20

30

40

Time (Min)

Figure 2.3: CB1 Mediates HFS-LTD. Two candidate receptors that could act as a pre-synaptic
target for eCBs include TRPV1 and CB1. A. The TRPV1 antagonist capsazepine failed to block
LTD, suggesting TRPV1 is not involved in this HFS-LTD (n=9, p=0.014). B. The CB1
antagonist AM-251 blocked LTD (n=9, p=0.03 compared to HFS control).
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Figure 2.4: Post-Synaptic 2-AG Mediates LTD Of VTA GABA Cells. A. Application of the
CB1 agonist Win55,212-2 depresses this synapse (n=6). There is a significant change between
baseline and drug application (p=0.002), but further HFS depression was occluded (p=0.57). B.
When the CB1 antagonist AM251 was present Win55,212-2 no significant change was observed,
further demonstrating the specificity of Win 55,212-2 for CB1 (n=5, p=0.86 compared to Win
55,212-2 only). C. Application of endogenous CB1 ligand 2-AG induces significant depression
(n=9, p=0.03). D. When the DAGLα inhibitor RHC 80267 was applied to block postsynaptic
production of 2-AG, HFS failed to produce a significant depression, suggesting that 2-AG is
produced post-synaptically in the GABA neuron (n=6, p=0.49). E-F. To further test for postsynaptic eCB production, depolarization induced suppression of excitation (DSE) was employed.
VTA GABA neurons were depolarized to 0 mV for 10 seconds to induce DSE. We observed a
persistent depression following DSE protocol (n=7, p=0.01), which was CB1 dependent, as it
was blocked by AM-251 (n=7).
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Figure 2.5: HFS-LTD Is Blocked In CB1 KO Mice. A. CB1 knock-out and heterozygous mice
were used to confirm CB1 involvement in the VTA. HFS in heterozygous mice caused a
significant depression compared to baseline (n=7, p=0.01). B. In CB1 knock-out mice, HFS
failed to produce LTD, further demonstrating the importance of CB1 in this plasticity (n=9,
p=0.34).
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Figure 2.6: THC Induces A CB1-Dependent Depression. A. THC is the psychoactive component
in marijuana, and a known CB1 agonist. When THC is applied to extracellular bath it produced a
lasting depression (n=6, p<0.001). B. Extracellular exposure to THC failed to produce
depression in the presence of AM251 (n=6, p=0.013, compared to THC without AM251). CB1
knock-out and heterozygous mice were used to confirm CB1 involvement. C. THC induced
depression in heterozygous mice (n=7, p=0.02). D. In CB1 KO mice, THC failed to produce
significant depression (n=9, p=.03). E. THC occluded HFS-LTD, suggesting THC and HFS-LTD
use the same pathway (p=0.003).
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Figure 2.7: Chronic THC Occludes HFS-LTD. A. We examined the effects of administering
THC via intraperitoneal injections. Chronic injections (7-10 consecutive days) of THC occluded
further depression following HFS (n=6) B. A single THC injection failed to occlude LTD (n=7,
p=0.019 compared to vehicle only controls). This suggests chronic THC is inducing synaptic
modifications that maybe comparable to drug-induced plasticity changes that alter addiction
behavior.
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Figure 2.8: Current Working Model. HFS-LTD is induced by CB1 activation that is mediated by
postsynaptically induced 2-AG, which is formed by PLC and DAGLα via mGluR5 activation
and postsynaptic calcium release. THC modulates this synapse via the CB1 pathway and/or
AMPA receptor expression.
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CHAPTER 3: Acute and Chronic Cocaine Exposure Occludes LTD
in Ventral Tegmental Area GABA Neurons
Lindsey N. Friend, Jeffrey G. Edwards
Abstract
The ventral tegmental area in the midbrain modulates reward. Drugs of abuse will
increase midbrain dopamine activity, and can alter ventral tegmental area glutamate plasticity
leading to addiction. While dopamine cells are the principal mediator of reward, they are
inhibited by nearby GABA cells. Our lab has demonstrated a form of pre-synaptic CB1
dependent long-term depression of glutamatergic inputs onto VTA GABA neurons. This
plasticity is dependent on mGluR5 and post-synaptic diacylglycerol lipase alpha. ∆9tetrahydrocannabinol, the active ingredient in marijuana can initiate this long-term depression at
this synapse by acute slice application, and occlude this plasticity following chronic injections.
Our aim was to determine whether cocaine can influence this plasticity. Using whole cell
voltage-clamp electrophysiology in GAD67-GFP mouse VTA slices, excitatory inputs on GABA
cells were isolated and recorded. Acute and chronic injections of cocaine were both sufficient to
occlude long-term depression. Furthermore, chronic cocaine decreased AMPA/NMDA ratios,
compared to vehicle only injections. The plasticity can be reversed to the naïve state, as longterm depression was again observed following 7 days of abstinence. This novel form of cocaineevoked plasticity wherein VTA GABA cells can depress excitatory inputs, which could lead to
disinhibition of nearby dopaminergic cells.
Introduction
Drug use leads to addiction and is a costly and debilitating disorder. Within the midbrain
is the ventral tegmental area (VTA) which mediates motivation and reward. The VTA is
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predominantly composed of dopamine cells that signal reward, and neighboring GABA cells that
inhibit them [14]. These dopamine cells are the target of drugs of abuse. All addictive
psychoactive substances examined to date induce long-term changes of excitatory synapses of
VTA DA neurons, while non-addictive psychoactive substances do not [16].
Cocaine has a robust and profound effect on modifying dopaminergic plasticity, indeed
cocaine modifies glutamatergic input to DA cells in every study examining this circuit in the
VTA to date [54]. Synaptic changes mediated by cocaine in DA cells include inhibition of longterm plasticity [55], increases in AMPA/NMDA ratios [17], decreases in AMPA rectification
indices [56], synaptic AMPA receptor subtype expression [57, 58], as well as indirectly altering
endocannabinoid physiology [50, 51, 59]. These synaptic alterations may be able to revert to the
naïve state following 1 week or more of abstinence [14].
Cocaine has been shown to influence CB1 plasticity, by influencing endocannabinoid
release [50], occluding eCB mediated LTD in the nucleus accumbens [49], which makes it an
ideal candidate drug to modify endocannabinoid plasticity. These effects have been studied at
synapses onto VTA dopamine cells, however, the effect of acute or chronic cocaine on
glutamatergic plasticity on GABA cells is unknown.
We have previously identified a novel form of plasticity on VTA GABA cells, that is
initiated by post-synaptic mGluR5, which leads to produce 2-AG synthesis that acts on
presynaptic cannabinoid 1 receptors. ∆9- tetrahydrocannabinol (THC), the active ingredient in
marijuana, can mimic this plasticity following slice application, and occlude it following chronic
intraperitoneal injections. Our goal was to examine the effect of cocaine on glutamate plasticity
in VTA GABA cells.
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Methods
All experiments were performed in accordance with Institutional Animal Care and Use
Committee protocols and followed NIH guidelines for the care and use of laboratory animals.
IACUC protocols for all experimental protocols were approved by the Brigham Young
University Institutional Animal Care and Use Committee, Animal Welfare Assurance Number
A3783-01.
Male Cd1 GAD67-GFP knock-in mice were used to identify GABA cells in the VTA.
15-30 day old mice were anesthetized with isoflurane and decapitated with a rodent guillotine.
Brains were rapidly removed and sectioned horizontally on a vibratome at 300 µm. Recordings
began at least one hour after cutting while tissue was stored in oxygenated cerebral spinal fluid
composed of 119 mM NaCl, 26 mM NaHCO3, 2.5mM KCl, 1 mM NaH2PO4, 2.5mM CaCl2,
1.3mM MgSO4, and 11mM glucose. 4mM picrotoxin (Abcam) was added to the recording
solution to block GABA currents. Spermine (0.1 mM) will be included in the patch electrode to
avoid polyamine dialyzation to maintain its block of GluR2-lacking AMPA receptors at
depolarized potentials, and is used to determine the subunit composition of synaptic AMPA
receptors via I-V plots.
The ventral tegmental area was visualized using an Olympus, BX51W1 microscope with
a 40x water immersion objective. Patch pipette resistance was 2.5–4.5 MΩ. Cells were held at
−65 mV prior to recording. Cells were patched with a glass pipette filled with internal solution
composed of 117mM potassium gluconate, 2.8mM NaCl, 20mM HEPES, 5mM MgCl2, and QX314 (Tocris) (pH 7.28, 275–285 mOsm). Cells were recorded under voltage clamp mode at -65
mV. Traces were recorded using Multiclamp 700B amplifier (Molecular Devices, Sunnyvale,
CA, USA). Signals were filtered at 4 kHz and digitized with an Axon 1440A digitizer
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(Molecular Devices) connected to a Dell personal computer with pClamp 10.2 Clampfit software
(Molecular Devices).
Plasticity was induced using 2 stimulations at 100Hz, 2 times, 20 seconds apart.
AMPA/NMDA ratios were obtained by patching cells at -70mV, allowing at least 10 minutes for
spermine to dialyze into the cell. The holding was raised to 40mV and APV was applied to
isolate the AMPA current. For IV plots, cells were stepped down from 40mV to -70mV, in
10mV increments. All other p-values were obtained by a students t-test comparing the 5 minutes
before conditioning to 15-20 minutes post conditioning.
Abcam supplied Picrotoxin (0.2mM). Tocris supplied APV (50µL). Sigma provided spermine
(0.1mM in internal pipette solution) and cocaine HCl which was administered via intraperitoneal injections at 15 mg/kg.
Results
Ventral tegmental area GABA neurons were positively identified using a GAD67-GFP
knock-in mouse line. These cells were patched using whole-cell voltage clamp electrophysiology
to record glutamate EPSCs. To induce GABA cells glutamatergic plasticity we used a 100Hz
high frequency stimulus (HFS) protocol. Following HFS there was a 40% reduction in EPSC
amplitude following HFS (Figure 3.1A). As many forms of glutamatergic plasticity require
NMDA, we examined the potential involvement of NMDA receptors. We observed HFS-LTD
was blocked in the presence of the NMDA receptor antagonist APV.
As cocaine is known to modify glutamatergic synapses to dopamine cells that are thought
to correlate to the creation of addiction and drug-addictive behavioral changes, we examined the
effect of cocaine on this novel plasticity in GABA cells.
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In order to investigate the possible role of cocaine in modulating this LTD, mice were
exposed to cocaine in vivo via intraperitoneal injections. Following chronic cocaine injections,
HFS failed to induce LTD (Figure 3.2A), which was significantly different than the chronic
saline vehicle injections (Figure 3.1A). Similarly, a single injection 24 hours prior to recording
also blocked LTD (Figure 3.2B). Cocaine-evoked plasticity can be reversed to the naïve state
following a period of abstinence. In order to determine whether LTD can be recovered, mice
were injected with a single dose of cocaine, followed by 7 days of abstinence. HFS induced LTD
similar to naïve mice (Figure 3.2C), suggesting synaptic changes following cocaine exposure do
not persist less than 7 days. These studies suggest cocaine can influence plasticity of VTA
GABA neurons, following a single injection.
An additional indication of drug evoked synaptic plasticity is alterations in AMPA to
NMDA ratios. VTA GABA neurons were patched and initially held at -70mV with spermine in
the intracellular solution. After waiting for 10 minutes for the spermine to dialyze into the cell,
the holding potential was raised to 40mV. Glutamate currents were recorded before and after the
application of the NMDA antagonist APV, and the ratios of AMPA to NMDA currents were
calculated. The AMPA/NMDA ratio from control mice exposed to chronic saline averaged 1.15,
while mice treated with chronic cocaine had a significantly decreased AMPA/NDMA ratio,
averaging 0.75 (Figure 3.2A).
In order to determine whether decreased AMPA/NMDA ratio was accompanied with
alterations in AMPA subunit expression, we analyzed IV plots to look for changes in
rectification that are indicative of GluR2-lacking AMPA subunits. AMPA currents were
measured from 40mV to -70mV, in 10mV steps. There was no significant difference in the
rectification of the AMPA currents, suggesting the change in AMPA/NMDA ratio was not
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accompanied by a change in AMPA subunit expression, but overall reduction in AMPA receptor
numbers (Figure 3.2 B).
Discussion
The results of the present study demonstrate the role VTA GABA neurons have in reward
physiology, and show an additional mechanism through which cocaine mediates synaptic
plasticity. Long-term depression can be initiated by 100Hz high frequency stimulus, and this
plasticity is blocked by both acute and chronic intraperitoneal injections of cocaine. One
injection of cocaine, followed by 7 days of abstinence allows the synapse to revert to a more
naïve form, wherein LTD is still elicited.
Previous studies have shown that increased GABA cell activity inhibits DA cell activity
and DA release [28, 30], therefore a depression of excitatory inputs onto GABA cells could
disinhibit dopamine release and increase reward. Thus, this depression could be an additional
means whereby the rewarding effects of cocaine are mediated.
Cocaine has been shown to influence excitatory plasticity in VTA dopamine cells [56],
and in medium spiny neurons projecting to the VTA [29]. Therefore, it is likely that cocaine
could have an impact influencing LTD at excitatory synapses to GABA cells, although to date
there has not been a study examining this effect. Cocaine has been implicated in modulating
plasticity through CB1 receptors. For example, cocaine can alter plasticity of GABA inputs onto
VTA DA cells [60]. This is particularly relevant as we have previously shown LTD at this
synapse is dependent on endocannabinoid signals and CB1 receptors.
An additional measure of drug-evoked plasticity is alterations in the ratio of AMPA to
NMDA receptors, as well as AMPA subunit expression. Changes in the AMPA receptor subunit
composition have been implicated in cocaine cravings and relapse [61]. Cocaine specifically can
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signal for the insertion of GluR2-lacking AMPA receptors, which are unique in their ability to
conduct calcium [62]. The plasticity described here does not appear to signal for GluR2 lacking
AMPA receptors, as the IV plots for the cocaine-treated animals are not strongly inwardly
rectifying. However, calcium could still be conducted through NMDA receptors and used as a
second messenger. NMDA receptors are required for the LTD described here and also for other
types of cocaine-evoked plasticity [63], as well as conditioned place preference [64].
Significance
Here we report a novel plasticity through which cocaine can modulate reward
physiology. This change can occur following a single exposure to cocaine. If GABA neurons
undergo long-term depression following cocaine use, this could result in disinhibition of the
neighboring dopamine neurons that signal reward.
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Figure 3.1: Long-Term Depression (LTD) In VTA GABA Cells Is NMDA-Dependent. A.
Glutamate currents recorded from GAD67-GFP positive VTA GABA cells from mice
chronically injected with saline. 100Hz high frequency stimulus (HFS) induces long-term
depression (n=6, p>0.05). B. In the presence of the NMDA receptor antagonist APV blocked
HFS-induced LTD (n=9), demonstrating dependence on NMDA receptors. Plots, mean with
s.e.m. Arrow indicates 100Hz high frequency stimulus (HFS). Scale bars 100 pA, 10 msec.
Plots, mean with s.e.m. Arrow indicates 100Hz high frequency stimulus (HFS).
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Figure 3.2: Chronic And Acute Cocaine Injections Block HFS-LTD. A. Chronic (7-10
consecutive days of intraperitoneal injections blocks HFS-induced LTD (n=6, p>0.05). B.
Similarly, 1 injection of cocaine is sufficient to block LTD (n=7, p>0.05) C. To determine
whether this plasticity can revert to the naïve state, mice were given a single injection of cocaine,
and plasticity was measured 7 days later. We again observed significant depression following 7
days of abstinence, suggesting the synapse can revert to a native state (n=7, p>0.05).
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Figure 3.3: Cocaine Decreases AMPA/NMDA Ratios. A. Alterations in the ratio of
AMPA/NMDA current provides additional evidence for plasticity. Chronic cocaine injections
significantly decreases AMPA/NMDA ratios (n=5, p<0.05). B. IV plots for chronic cocaine and
saline treated mice. There was no significant difference in rectification indices between the
experimental groups (n=6). C. Measuring current at -70mV and at -40mV is another way to
determine if there are changes in rectification. No significant change was observed (n=6).
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CHAPTER 4: Hippocampal Stratum Oriens Interneurons undergo a CB1-dependent Potentiation
Lindsey Friend, Ryan Williamson, Collin Merrill, Scott Newton,
Michael Christensen, Jeffrey G. Edwards
Abstract
The hippocampus is thought to mediate learning and memory by altering synaptic
strength within its circuitry. In many cases, synaptic plasticity can be induced by signaling
molecules such as lipid-based endocannabinoids like anandamide. Endocannabinoids modulate
synaptic plasticity of hippocampal pyramidal cells and stratum radiatum interneurons; however,
the role of endocannabinoids in mediating synaptic plasticity among interneurons in the stratum
oriens is still unclear. These interneurons are feedforward inhibitory cells that have unique
synaptic plasticity compared to those in the radiatum as they exhibit presynaptic LTP, rather than
LTD. This plasticity is TRPV1 and nNOS independent. We therefore examined whether oriens
interneurons can produce endocannabinoids and whether these might be involved in presynaptic
LTP. Using patch-clamp electrodes to extract single cells, we analyzed the expression of
endocannabinoid biosynthetic enzyme mRNA using real-time, reverse transcription PCR. The
cellular expression of several calcium-binding proteins and neuropeptides were used to identify
interneuron subtypes. We also analyzed cellular expression of several endocannabinoid
biosynthetic enzymes. qPCR results demonstrate that sratum oriens interneurons do express
mRNA for both biosynthetic enzymes and the type I mGluRs necessary for their production. To
test the role of endocannabinoids in synaptic plasticity, we performed whole-cell experiments
and measured glutamate currents in the presence of a fatty acid amide hydrolase inhibitor
(URB597; 1µM), which increases endogenous anandamide. Interestingly, URB597 potentiated
stratum oriens interneurons in a CB1-dependent manner as it was blocked by AM-251 (2 µM).
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Furthermore, high frequency stimulus can induce long-term potentiation in somatostatin-positive
cells. This plasticity was also blocked by AM-251, further demonstrating CB1 dependence.
Collectively, this suggests oriens interneurons express the cellular machinery needed for
endocannabinoid production, and can alter their plasticity in response to anandamide signal.
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Introduction
Synaptic Plasticity is a process whereby synapses can be strengthened or weakened based
on the activity of the cells around them by either presynaptically altering neurotransmitter
release, or postsynaptically modifying the receptor trafficking to and from the membrane.
Plasticity is a critical event that allows for modification of brain in an experience-dependent
fashion. Two major forms of synaptic plasticity are present in the brain, Long-term potentiation
(LTP) and long-term depression (LTD). For post-synaptic LTP to occur, there must be a large
calcium ion influx through N-Methyl-D-Aspartate (NMDA) glutamate receptors, which triggers
α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors to be inserted into
the membrane [65]. Plasticity has been observed in various brain regions, notably, the
hippocampus where it is crucial for memory encoding and consolidation. Other less well known
forms of plasticity in addition to NMDA-dependent forms also occur in the brain that are
mediated by various other mechanisms such as lipid messengers known as endocannabinoids.
Endocannabinoids (eCBs) are produced by components of the lipid membrane, a reaction
catabolized by various enzymes, for example phospholipase D, diacylglycerol lipase alpha
(DAGLα), 12, lipoxygenase, normally following second messenger activation [4, 6, 23, 33, 66].
Usually, upon post-synaptic activation of type 1 metabotropic glutamate receptors, enzymes are
recruited to produce eCBs which then retrogradely act on presynaptic receptors to alter
neurotransmission via g-protein coupled channels such as cannabinoid receptor 1 (CB1) [3]. The
two best characterized endocannabinoids are anandamide and 2-arachadonyl glycerol (2-AG).
Anandamide, a common eCB, is produced by n-acylphosphatidylethanolamine phospholipase D
(NAPE-PLD) and can bind to CB1, TRPV1 and other GPRs throughout the brain. It is then
degraded by the enzyme fatty acid amide hydrolase (FAAH) [4, 5]. 2-AG is produced in the
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brain by diacylglycerol lipase alpha (DAGLα) and is also involved in retrograde signaling via
CB1 [6] and other receptors. It remains unknown whether some or all of the various subtypes of
oriens interneurons utilize this form of plasticity.
Distributed in hippocampal layers are both excitatory and inhibitory neurons. Excitatory
pyramidal cells are located in stratum pyramidale and diverse inhibitory interneurons are present
in stratum radiatum and stratum oriens [2]. Hippocampal interneurons are a diverse group, and
can be classified into several different subtypes based on their function, projections and firing
pattern. Often interneurons are characterized into groups using calcium binding proteins and
neuropeptides, including somatostatin, cholecystokinin and parvalbumin. The stratum oriens of
the CA1 region of the hippocampus houses interneurons of varying types. Oriens lacunosummoleculare (O-LM) interneurons are one such group, and can be identified by the expression of
somatostatin, as well as a regular and fast spiking pattern and sag potential upon injection of
hyperpolarizing current [7, 8]. O-LM cells are named for their morphology, with somas residing
in stratum oriens and distant projections to stratum lacunosum moleculare. Another subtype is
parvalbumin positive basket cells, which project locally and lack a sag potential. These cells are
also involved in network oscillations in the hippocampus [9]. While projections and spiking
patterns are well defined in these neurons, information regarding the mechanism of eCBdependent plasticity of these interneurons is scarce but promising.
Stratum oriens interneurons exhibit plasticity, but markedly unique compared to
neighboring interneuron layers such as the stratum radiatum. For example, the group 1 mGluR
agonist DHPG will depress radiatum interneurons [67], but it will potentiate oriens interneurons
[68]. There is an anti-hebbian form of pre-synaptic potentiation that can be induced in putative
O-LM cells by 100 Hz high frequency stimulus (HFS), which is independent of nitric oxide and
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TRPV1 [8], but dependent on mGluRs, post-synaptic calcium and M1 muscarinic receptors [69].
our goal was to determine whether this plasticity is dependent on eCBs.
Based on the role interneurons play in feed-forward inhibition of CA1 pyramidal cells
and widespread network control and oscillations, and given they also undergo plasticity, it is
important to characterize this novel form of LTP. Here we report stratum oriens interneurons
have the capability to produce eCB biosynthetic enzymes, and can induce LTP in a CB1dependent manner.
Methods
All experiments were performed in accordance with Institutional Animal Care and Use
Committee protocols and followed the NIH guidelines for the care and use of laboratory animals.
Male Sprague-Dawley rats age 15-30 days old were used for all electrophysiological
experiments. Rats were anesthetized with isoflurane and decapitated. Brains were removed and
sectioned coronally on a vibratome at 400 µm. Recordings began at least one hour after cutting
while tissue was stored in oxygenated cerebral spinal fluid composed of 119 mM NaCl, 26 mM
NaHCO3, 2.5mM KCl, 1 mM NaH2PO4, 2.5mM CaCl2, 1.3mM MgSO4, and 11mM glucose.
4mM picrotoxin (Abcam) was added to the recording solution to block GABA currents.
Hippocampal oriens CA1 cells were visualized using an Olympus, BX51WI microscope
with a 40x water immersion objective. Cells were patched with a glass pipette filled with internal
solution composed of 117mM potassium gluconate, 2.8mM NaCl, 20mM HEPES, 5mM MgCl2,
and QX-314 (Tocris) (pH 7.28, 275–285 mOsm). Cells were recorded under voltage clamp mode
at -65 mV. Plasticity was induced using 2 stimulations at 100Hz, 20 seconds apart, while the cell
was in current clamp, then recording resumed in voltage clamp mode. Traces were recorded
using Multiclamp 700B amplifier (Molecular Devices, Sunnyvale, CA, USA). Signals were
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filtered at 4 kHz and digitized with an Axon 1440A digitizer (Molecular Devices) connected to a
Dell personal computer with pClamp 10.2 Clampfit software (Molecular Devices).
Cells used for PCR analysis were extracted using gentle suction and placed into chilled
reverse transcriptase reagents (BioRad) within 2 hours. One control sample of artificial cerebral
spinal fluid was obtained for each slice and used to identify contamination from extracellular
mRNA. Using iScript cDNA Synthesis kit (BioRad), extracted cells were reverse transcribed to
cDNA under the manufacturers protocol and cycled in a C1000 Thermocycler (BioRad) at 25°C
for 8 min, 42°C for 60 min, and 70°C for 15 min. Following reverse transcription, each cell was
divided into three 5µL aliquots which each received a different group of 10-fold diluted primers,
iQ Supermix (BioRad), and ddH20. Additional no template control tests were done to ensure
there were no primer dimer or hairpin interactions. The samples were then cycled in a C1000
Thermocycler (BioRad) starting at 95°C for 3 minutes, then 15 cycles of 95°C for 15 minutes,
57°C for 20 seconds, and 72°C for 25 seconds. All other p-values were obtained by a students ttest comparing the 5 minutes before conditioning to 15-20 minutes post conditioning.
Most primer and probe sequences were used in our previous study [70]. Primers were
designed for somatostatin using the same parameters, efficiency and melting temperature using
the Vector NTI software. The somatostatin forward, reverse and probe sequences used were
ACCCCAGACTCCGTCAGTTTC, GTTGGGCTCAGACAGCAGTTCT, and
ACCGGGAAACAGGAACTGGCCAAGT respectively.
Each pre-amplified cell was run for every target individually and in triplicate. Each cell
was run in a CFX96 qPCR machine (BioRad) with a 95°C hot start for 3 minutes, followed by 60
cycles of 95°C for 15 seconds, 57°C for 25 seconds, and 72°C for 25 seconds. Cycle threshold
(Ct) values were determined by the BioRad software.
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Results
The goal of our study was to investigate the role of endocannabinoid signaling in
mediating LTP in stratum oriens interneurons. We hypothesized that stratum oriens inhibitory
neurons possess the machinery necessary for endocannabinoid synthesis and that this machinery
was involved in an interneuron mediated LTP. To test this, we extracted putative inhibitory
neurons from stratum oriens using patch clamp electrophysiology and then performed RT-qPCR
to examine components involved in endocannabinoid biosynthesis. Classification of cells as
interneurons was done based on GAD65 and GAD67 mRNA expression. In addition, we further
classified putative inhibitory neurons into three subtypes: somatostatin and cholecystokinin
expression (SOM+/CCK+), parvalbumin expressing (PV+), and calretinin or calbindin
expressing (CR+/CB+). Our results are summarized in Table 1. SOM+/CCK+ neurons were the
most abundant (n=14) and expressed mRNA for DAGLα, NAPE-PLD, 12-Lipoxygenase and
type 1 mGluRs. PV+ cells were the second largest group, and expressed mRNA for NAPE-PLD,
12-Lipoxygenase and type 1 mGluRs. CR+/CB+ cells were the minority, and only one such cell
expressed mRNA for any of the eCB enzymes.
We next used patch clamp electrophysiology to examine the physiological role of eCB
production in previously identified stratum oriens potentiation. To do this, we first recorded
glutamate EPSCs from oriens interneurons before and after a fatty-acid amide hydrolase (FAAH)
inhibitor was applied to the extracellular solution. FAAH inhibition prevents anandamide
hydrolysis and increases synaptic levels of anandamide. We found FAAH inhibition produced a
significant potentiation compared to baseline (Figure 4.1A). This potentiation was blocked by the
CB1 antagonist AM-251 (Figure 4.1B) demonstrating CB1 dependence.
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To determine whether the plasticity seen with the FAAH inhibitor is related to the
plasticity previously observed, 100Hz high frequency stimulation (HFS), we applied HFS to
oriens interneurons (Figure 4.2A) and saw LTP in 63% of interneurons. LTP was blocked the
observed plasticity with AM251 (Figure 4.2B). These experiments further confirm the
involvement of CB1. When the mRNA was examined, we observed that somatostatin positive
cells would potentiate (Figure 4.2C), while somatostatin negative cells would not (Figure 4.2D).
Furthermore, LTP of somatostatin-positive neurons was blocked in the presence of AM-251
(Figure 4.2E). This confirms LTP occurs only in O-LM cells, and that this LTP is dependent on
CB1.
As the PCR data suggested that oriens interneurons could produce the proteins necessary
to produce the anandamide involved in this plasticity, we performed a test of eCB production
known as depolarization-induced suppression of excitation (DSE). In this protocol, cells were
initially held at -65mV, then raised to 0mV for 10 seconds, after which the cell remained at 65mV for the duration of the experiment. DSE experiments in oriens interneurons showed no
change glutamate current amplitude, suggesting that the eCBs involved in plasticity are likely
made elsewhere (Figure 4.3).
Discussion
We found that parvalbumin and somatostatin positive cells express mRNA required to
receive and produce an eCB signal, and that the eCB anandamide can be used to potentiate
oriens interneurons in a CB1 dependent manner. Single-cell PCR revealed that somataostatinpositive cells will respond to HFS. This is the first demonstration of eCB biosynthetic enzyme
expression in a subtype-specific manner, and CB1 dependence in oriens LTP.

47

Hippocampal levels of type 1 mGluRs have been previously studied, and appeared higher
than those reported here [68, 71]. Single cell reverse-transcriptase polymerase chain reaction
(RT-PCR) has been employed extensively to quantitatively test levels of mRNA, however, this
method can slightly underestimate the actual levels. This discrepancy could have resulted from
alterations in primer efficiency or be an effect of multiplexing. It is likely that the actual
proportion of oriens interneurons that express type1 mGluRs is equal to or greater than the
proportion of neurons that exhibited anandamide dependent LTP, as mGluRs are required to
signal PLD, and therefore anandamide production.
Several subtypes of oriens interneurons have been identified based on their morphology,
protein content, and plasticity. The relative ratios of oriens cell types shown here is similar to
what others have seen in the hippocampus [2]. For example, the majority cell type observed was
somatostatin-positive O-LM cells. Somatostatin-positive neurons have been previously shown to
undergo LTP [72], which is consistent with our current findings. Additionally,
calretinin/calbindin positive cells were the minority. Calretinin-positive cells have been
implicated in regulating the activity of other interneurons, and tend not to possess eCB
machinery [73].
Endocannabinoid signaling in the hippocampus has been previously studied by multiple
groups [74], and has particular importance for GABA cells [75]. Therefore, it was likely that
oriens interneurons also participate in this type of signaling. The radiatum and pyramidal cell
layers express eCB mRNA [70], however, this is the first study that examined the eCB synthetic
capability of oriens interneurons.
The anandamide-dependent plasticity observed here signals through CB1 receptors.
Typically CB1 activation results in long-term depression [76]. However, a presynaptic CB1-
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mediated potentiation is consistent with Kullmann et al observations. The mechanism through
which CB1 signals for potentiation is unknown, although there are several possibilities. For
example, CB1 could be coupling to different g-proteins intracellularly or signaling for increases
in terminal size. Alternatively, the increased anandamide levels could be causing a decrease in 2AG levels, as observed in the striatum [77], thus, disinhibiting oriens interneurons. Indeed, this is
a matter of current investigation.
Significance
The results of the present study demonstrate hippocampal stratum oriens interneurons
have the potential to make eCB synthetic proteins and receptors. Further, oriens cells can use
anandamide to potentiate glutamatergic inputs in a CB1 dependent manner. This is also the first
demonstration of a CB1-dependent long-term potentiation in the hippocampus, suggesting a
broader and more variable role of CB1 and other endocannabinoids. The diverse subtypes of
oriens interneurons have projections throughout the hippocampus, and understanding the
plasticity of these cells is a step to understanding hippocampal circuitry overall.
Acknowledgements
National Institute of Neurological Diseases and Stoke grant R15NS078645, and National
Institute of Drug Abuse grant R15DA038092 from the National Institutes of Health supported
this work. The content is solely the responsibility of the authors and does not necessarily
represent the official views of the National Institute of Neurological Disorders and Stroke,
National Institute of Drug Abuse or the National Institutes of Health. This work was also
supported by institutional Mentoring Environment Grants (JE) and Brigham Young University
Graduate Fellowship Awards (LF).

49

Table 4.1: Summary Of RT-PCR Data. Individual stratum oriens interneurons were patched and
extracted for mRNA examination. Cells were sorted by subtype and by endocannabinoid
synthetic enzyme expression. Somatostatin-positive cells were the most abundant, followed by
parvalbumin positive cells, and finally calretinin/calbindin interneurons. Somatostatin and
parvalbumin positive cells had the highest expression of endocannabinoid and mGluR related
mRNA.

50

B.

2.0
URB597 (1um)

1.5
1.0
0.5
0.0

0

5

10

15

2.0

Normalized ESPCs

Normalized EPSCs

A.

20

25

1.5

URB597 (1um)

1.0
0.5
0.0

30

Time (Min)

AM-251 (2um)

0

5

10

15

20

25

30

Time (Min)

Figure 4.1: FAAH Inhibition And HFS Potentiate Oriens Interneurons In A CB1 Dependent
Manner. Stratum oriens interneurons were patched (n=8) in whole cell mode and recorded while
the enzyme fatty acid amide hydrolase (FAAH) was inhibited by URB-597. A. A significant
(p>.05) potentiating effect was observed suggesting a role of anandamide in oriens synaptic
plasticity. B. FAAH induced potentiation is blocked in the presence of the CB1 antagonist AM251 (n=7). Scale bars 100 pA, 10 msec. Plots, mean with s.e.m. Arrow indicates 100Hz high
frequency stimulus (HFS).
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Figure 4.2: HFS-LTP Only Occurs In Somatostatin-Positive Interneurons, And Is CB1
Dependent. A) Oriens interneurons were patched and exposed to 100 Hz HFS (Figure 2.A) A
significant potentiation followed (n=8, p<0.05), which was blocked by AM-251 (Figure 2.B),
suggesting it is also dependent on CB1 C. An example cell that was somatostatin-positive, and
exhibited HFS-LTD, along with an O-LM spiking profile. D. Parvalbumin-positive
(somatostatin negative) neuron that did not potentiate following HFS, with spiking figure typical
for PV-positive interneurons. E. A somatostatin-positive neuron, that likely could have
potentiated. This cell did not exhibit plasticity in the presence of the CB1 antagonist AM251.
Collectively, these experiments suggest that parvalbumin positive cells will not potentiate,
somatostatin positive (putative O-LM cells) can exhibit LTD following HFS, and that this
plasticity is dependent on CB1 receptors.
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Figure 4.3: No Change In DSE Suggests eCBs Involved In LTP Are Not Made In The Oreins.
Depolarization-induced suppression of excitation experiments to determine whether the eCBs
involved in the CB1-dependent plasticity were produced in the oriens interneurons. Interneurons
were depolarized to 0mV for 10 seconds, then returned to -65mV. There was no significant
change following 10 second depolarization to 0mV, suggesting eCBs involved in this plasticity
are not made in the oriens (n=6).
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CHAPTER 5: Conclusion
The purpose of this work was to determine the mechanism of plasticity in VTA GABA
neurons, and in stratum oriens interneurons. In the VTA, we described a novel form of presynaptic plasticity dependent on CB1. This plasticity can be occluded by THC and cocaine,
demonstrating a link between drugs of abuse and the LTD here observed. In the oriens, we
showed eCB biosynthetic capability, as well as a unique type of CB1-dependent LTP.
Future studies will examine the location of the glutamatergic inputs onto VTA GABA
cells that participate in the LTD described here. Once they can be isolated and selectively
activated, dopamine cells will be recorded before and after LTD induction to confirm
disinhibition of dopamine cells. For the LTP in oriens interneurons, future work can be done to
elucidate the unique signaling cascades that allow CB1 to initiate potentiation rather than
depression.
Collectively, these experiments illustrate the importance of eCBs in modifying synaptic
plasticity in the brain. eCBs can be use variably to promote LTD or LTP. Furthermore, eCBs can
participate in modifying plasticity involved in reward and memory circuits, demonstrating the
diverse impact eCBs have. Understanding the native condition of the eCB system and details of
synaptic plasticity is a step toward uncovering the mechanism through which pathologies such as
drug addiction and Alzheimer’s disease are developed.
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